and serves on a speaker's bureau for AstraZeneca, Novo Nordisk, Eli Lilly, Sanofi, Merck Sharp & Dohme, Boehringer Ingelheim and Janssen
The latest research and trials on the effect of GLP-1RAs in the eye were searched until April 2025, including thorough cellular studies, animal studies, and clinical observation surrounding glaucoma, diabetic retinopathy, and other ocular diseases
Ozempic Results Clinical trials indicate that patients using Wegovy achieve an average weight loss of approximately 15-18% over 68 weeks with healthy eating and exercise
PubMed Kim, S.B., Kwon, D.R., Kwak, H., Shin, Y.B., Han, H.J., Lee, J.H., & Choi, S.H
Current research investigating potential advantages beyond glycaemic regulation and weight reduction, including impacts on non-alcoholic fatty liver disease, cardiovascular outcomes, and renal protection, may broaden the therapeutic uses of these medicines
Long vs